Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Current Assets: 2018-2024

Historic Current Assets for Whitehawk Therapeutics (WHWK) over the last 7 years, with Dec 2024 value amounting to $61.3 million.

  • Whitehawk Therapeutics' Current Assets rose 113.46% to $165.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $165.0 million, marking a year-over-year increase of 113.46%. This contributed to the annual value of $61.3 million for FY2024, which is 50.81% down from last year.
  • According to the latest figures from FY2024, Whitehawk Therapeutics' Current Assets is $61.3 million, which was down 50.81% from $124.6 million recorded in FY2023.
  • In the past 5 years, Whitehawk Therapeutics' Current Assets ranged from a high of $180.0 million in FY2022 and a low of $18.7 million during FY2020.
  • In the last 3 years, Whitehawk Therapeutics' Current Assets had a median value of $124.6 million in 2023 and averaged $122.0 million.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Current Assets crashed by 52.78% in 2020, and later soared by 709.59% in 2021.
  • Yearly analysis of 5 years shows Whitehawk Therapeutics' Current Assets stood at $18.7 million in 2020, then skyrocketed by 709.59% to $151.3 million in 2021, then climbed by 19.01% to $180.0 million in 2022, then crashed by 30.80% to $124.6 million in 2023, then crashed by 50.81% to $61.3 million in 2024.